The global eye examination equipment market size was valued at USD 5.5 billion in 2017. It is anticipated to witness a CAGR of 6.2% during the forecast period. Growing demand for early and accurate detection of medical conditions along with advent of advanced surgical ophthalmic devices is estimated to be one of the key trends stimulating market growth over the forecast period.
Rising incidence of ophthalmic disorders, especially glaucoma, diabetic retinopathy, and AMD is also supplementing the growth of the market. Expanding base of global geriatric population is also playing a vital role in the development of the market as aged people are more susceptible to eye related problems.
According to statistics published by the National Institute of Health in 2017, around 2.4 million population in the U.S. aged 40 and older have cataracts in their eyes, and this number is expected to increase tremendously over the forecast period. This shows the potential demand for ophthalmic treatments, which will thereby boost the growth of the market. In addition, growth in private and public healthcare sectors and introduction of advanced equipment vision care practices are among the key growth stimulants for the market.
Moreover, increasing usage of contact lenses and surgical ophthalmic devices during refractive error correction surgery is providing a significant push to the market. Furthermore, high unmet medical needs in emerging economies are likely to stir up the use of modern ophthalmic devices.
Based on product, the market is segmented into optical coherent tomography scanners (OCT), ophthalmic ultrasound imaging, corneal topography systems, Slit lamps, tonometer, ophthalmoscopes, perimeters/visual field analyzers, fundus cameras, and autorefractors and keratometers. OCT accounted for the largest revenue share the global market in 2017. Increasing prevalence of glaucoma and scotoma are key factors contributing to the dominance of the segment. According to statistics published by the National Institute of Health, in 2017 around 2.7 million population in the U.S. aged 40 and above had glaucoma in their eyes.
Moreover, ophthalmic ultrasound imaging systems, slit lamps, and corneal topography systems are poised to witness steady growth in the coming years due to growing demand for modern ophthalmic treatments. Other ophthalmic devices include tonometer, ophthalmoscopes, perimeters/visual field analyzers, fundus cameras, and autorefractors and keratometers (phoropters).
The hospitals segment accounted for the largest share in the eye examination equipment market in terms of revenue in 2017 as most numbers of ophthalmic surgeries are performed in these facilities. The statistics published by the National health statistics indicate that in May 2015 around 48,229 corneal transplants were performed in the U.S. and this number is increasing remarkably every year.
However, high treatment cost in outpatient department can retard the growth of the segment over the forecast period. The clinics segment is projected to exhibit lucrative growth during the forecast period due to comparatively cheaper treatment than hospitals and also greater availability of surgeons.
North America accounted for just over 43.0% of the overall market in 2017. This is due to the presence of a well-developed healthcare setting for ophthalmic treatments. Moreover, the presence of favorable reimbursement network and government funding are some other factors contributing to the growth of the regional market.
The market in Asia Pacific is expected to rise at a CAGR of 7.0% during the forecast period due to increasing geriatric population. Growing investments by governments and other private organizations for tackling high unmet needs in the healthcare sector in the region is likely to spur the growth of the market.
The market is marked by the presence of various small and large surgical and medical device manufacturing companies offering products for ophthalmic treatments. The market is competitive in nature. It is dominated by participants such as Carl Zeiss Meditec AG; Bausch & Lomb Inc.; and Johnson & Johnson Vision Care Inc. Other market participants contributing significantly are Novartis AG, NIDEK CO., LTD, Canon, and HEINE Optotechnik.
Companies are focusing on implementing strategies such as regional expansion, new product development through advanced technologies, partnership, and distribution agreements to increase their revenue share. For instance, in April 2018, Nidek launched a new business unit in Korea to expand its geographical footprint. Furthermore, in August 2017, ZEISS acquired Veracity Innovations, LLC, a cloud-based platform in an attempt to improve clinical efficiency of its products pertinent to cataract surgery.
Report Attribute |
Details |
Market size value in 2020 |
USD 6.5 billion |
Revenue forecast in 2025 |
USD 8.8 billion |
Growth Rate |
CAGR of 6.2% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, end use, region |
Regional scope |
北美;欧洲;亚太地区;拉丁美洲; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Bausch & Lomb Inc; Carl Zeiss Meditec AG; Alcon Inc; Johnson & Johnson Vision Care Inc.; Bausch & Lomb Incorporated; ESSILOR INTERNATIONAL S.A.; Ziemer Ophthalmic Systems AG; NIDEK CO. LTD.; TOPCON MEDICAL SYSTEMS, INC.; HAAG-STREIT; VISIONCARE INC. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global eye examination equipment market report on the basis of product, end-use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Optical coherent tomography scanners (OCT)
Ophthalmic ultrasound imaging systems
Ophthalmic A-Scan Ultrasound
Ophthalmic B-Scan Ultrasound
Corneal topography systems
Slit lamps
Tonometer
Ophthalmoscopes
Perimeters/visual field analyzers
Fundus cameras
Autorefractors and Keratometers (phoropters)
Others
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Clinics
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
拉丁美洲
Brazil
Mexico
Middle East & Africa
South Africa
b.Key factors that are driving the market growth include rising prevalence of eye diseases, technological advancements in ophthalmic surgical and diagnostic instruments, and government initiatives for increasing awareness related to visual impairment.
b.The global optometry/eye examination equipment market size was estimated at USD 6.1 billion in 2019 and is expected to reach USD 6.5 billion in 2020.
b.The global optometry/eye examination market is expected to grow at a compound annual growth rate of 6.2% from 2019 to 2025 to reach USD 8.8 billion by 2025.
b.北美主导examinat验光/眼睛ion market with a share of 43.0% in 2019. This is attributable to significant advances in ophthalmic surgical procedures and devices, which helped improve diagnosis and treatment of various ophthalmic diseases, including retinal disorders, glaucoma, or refractory disorders.
b.Some key players operating in the optometry/eye examination market include Bausch & Lomb Inc, Carl Zeiss Meditec AG, Alcon Inc, Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, ESSILOR INTERNATIONAL S.A., Ziemer Ophthalmic Systems AG, NIDEK CO. LTD., TOPCON MEDICAL SYSTEMS, INC., HAAG-STREIT, and VISIONCARE INC.
"The quality of research they have done for us has been excellent."